103 results
8-K
EX-1.1
LPCN
Lipocine Inc
26 Apr 24
Entry into a Material Definitive Agreement
5:20pm
Materials Furnished to the Sales Agent. Copies of the Registration Statement, the Prospectus, and all amendments or supplements thereto and all … preceding the date of this Agreement (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein being
8-K
LPCN
Lipocine Inc
11 Apr 24
Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity
7:24am
a webcast/conference call presenting positive clinical trial results. The Company’s materials to be used in the presentation are filed hereto as Exhibit 99.2
8-K
k4nmls0l3c7t7mb
13 Nov 23
Lipocine Releases Late Breaking Presentation on LPCN 1148 Phase 2 Results at The Liver Meeting® 2023
2:45pm
8-K
btjbi9d
27 Jul 23
Other Events
6:45am
8-K
1aeqyt5s2dmv
26 Jun 23
Other Events
9:15am
8-K
0cdf6b
23 Jun 23
Other Events
4:19pm
8-K
b98xkb30f9j
16 May 23
Positive Topline Clinical Results Support Streamlined Development Pathway for LPCN 1154, Lipocine’s Oral Candidate for Rapid Relief of Depression
7:00am
8-K
v7xehfh eikqm91hrr
4 Nov 22
Other Events
4:43pm
8-K
gxv045fq
27 Oct 22
Other Events
9:52am
8-K
EX-99.1
6aiy4sg3
9 Mar 22
Other Events
8:00am
8-K
ji7z ctwqc8
4 Jan 22
Other Events
8:00am